Genetic roadmap could revolutionize AML treatment for older adults
Knowledge-focused
Recruiting now
This study aims to see if quickly analyzing the genetic makeup of a person's leukemia can help doctors choose the best targeted therapy for them. It involves 3,000 adults, mostly aged 60 and older, with newly diagnosed or returning acute myeloid leukemia (AML). Participants recei…
Phase: PHASE1, PHASE2 • Sponsor: Beat AML, LLC • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC